Feedback unseren Kunden
Ihr Warenkorb
€0.00 (0 artikel)
Search:
Perform search
Produktkategorien

Generisches Lamivudine - Combivir, Epivir

News
Suche nach Anfangsbuchstaben:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Combivir
Generisches Combivir gehört in die Medikamenten Gruppe der sogenannten Transcriptase-Hemmer und behandelt in Kombination mit anderen Medikamenten HIV-Infektionen.
€1.30
Epivir
Generisches Epivir wirkt in Kombination mit anderen Medikamenten bei HIV-Infektionen.
€1.56

Tag: lamivudine manufacturer india, combivir rezeptfrei, lamivudine syrup, combivir ultra rezeptfrei kaufen, lamivudine mit online altes, combivir preis apotheke, lamivudine in luxemburg kaufen, combivir kaufen paris, lamivudine verkauf preis, combivir interaktionen.

Soziale Lesezeichen
    Choose your language:



    Geld zurückGarantie
    Sichereinkaufen

    Unsere Rechnungsführung ist zertifiziert durch:

    Secure shopping certificates

    Special Offer!

    • This RSS feed URL is deprecated

      This RSS feed URL is deprecated, please update.

    • ViiV submits two-drug regimen for HIV in Europe - PharmaTimes

      PharmaTimesViiV submits two-drug regimen for HIV in EuropePharmaTimesViiV Healthcare has submitted an application in Europe for a single-tablet, two-drug regimen of dolutegravir (DTG) and lamivudine (3TC) for the treatment of HIV-1 infection.

    • FDA Approves Merck's DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed ... - Business Wire (press release)

      Business Wire (press release)FDA Approves Merck's DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed .

    • Aurobindo Pharma gets nod from South African health authority for HIV drug - Business Today

      Business TodayAurobindo Pharma gets nod from South African health authority for HIV drugBusiness TodayAurobindo Pharma on Tuesday said it has received approval from the South African health authority to market its Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (DLT) tablets, the first-line regimen for HIV patients as per latest WHO guidelines.

    • Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV - Nasdaq

      NasdaqGlaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIVNasdaqGlaxoSmithKline GSK announced that its HIV-focused company, ViiV Healthcare submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for a single-tablet, two-drug regimen of dolutegravir (Tivicay) and lamivudine .

        Copyright © www.ohnerezeptfreikauf.com is an affiliate marketing website. All rights reserved.